These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 7537757)

  • 1. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.
    Singer II; Kawka DW; Bayne EK; Donatelli SA; Weidner JR; Williams HR; Ayala JM; Mumford RA; Lark MW; Glant TT
    J Clin Invest; 1995 May; 95(5):2178-86. PubMed ID: 7537757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
    van Meurs J; van Lent P; Stoop R; Holthuysen A; Singer I; Bayne E; Mudgett J; Poole R; Billinghurst C; van der Kraan P; Buma P; van den Berg W
    Arthritis Rheum; 1999 Oct; 42(10):2074-84. PubMed ID: 10524678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis.
    van Meurs JB; van Lent PL; Holthuysen AE; Singer II; Bayne EK; van den Berg WB
    Arthritis Rheum; 1999 Jun; 42(6):1128-39. PubMed ID: 10366105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: a pivotal role for stromelysin-1 in cartilage destruction.
    van Meurs J; van Lent P; Holthuysen A; Lambrou D; Bayne E; Singer I; van den Berg W
    J Immunol; 1999 Nov; 163(10):5633-9. PubMed ID: 10553093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice.
    Chambers MG; Cox L; Chong L; Suri N; Cover P; Bayliss MT; Mason RM
    Arthritis Rheum; 2001 Jun; 44(6):1455-65. PubMed ID: 11407708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
    Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
    J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis.
    van Meurs JB; van Lent PL; Singer II; Bayne EK; van de Loo FA; van den Berg WB
    Arthritis Rheum; 1998 Apr; 41(4):647-56. PubMed ID: 9550473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen II-induced arthritis.
    Singer II; Scott S; Kawka DW; Bayne EK; Weidner JR; Williams HR; Mumford RA; Lark MW; McDonnell J; Christen AJ; Moore VL; Mudgett JS; Visco DM
    Osteoarthritis Cartilage; 1997 Nov; 5(6):407-18. PubMed ID: 9536289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
    Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
    Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR; Okouneff S; Ionescu M; Poole AR
    Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis.
    van Lent PL; Grevers L; Blom AB; Sloetjes A; Mort JS; Vogl T; Nacken W; van den Berg WB; Roth J
    Ann Rheum Dis; 2008 Dec; 67(12):1750-8. PubMed ID: 18055478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ; Last K; Maciewicz RA
    J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
    van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.